Oral Hypoglycaemic Drug

Oral Hypoglycaemic Drug: what is it and how is it used to treat type II diabetes mellitus

Type II diabetes is a disease in which blood glucose levels are elevated due to the body's insufficient use of insulin. Treatment for this condition may include lifestyle changes such as eating right and exercising, as well as taking medications. Oral Hypoglycaemic Drug is one such drug that helps lower blood glucose levels.

These medications are taken orally and are available in tablet or capsule form. They affect blood glucose levels by stimulating the production of insulin in the pancreas, improving the body's use of insulin, and also reducing the amount of glucose secreted by the liver. As a result, blood glucose levels decrease.

These include drugs containing sulfonylureas such as chlorpropamide, glibenclamide and tolbutamide, as well as metformin (a biguanide). Sulfonylureas stimulate the production of insulin in the pancreas. They can cause side effects such as hypoglycemia (blood glucose levels too low), allergic reactions and liver problems.

Metformin, on the other hand, reduces the amount of glucose released by the liver and improves the body's use of insulin. It does not usually cause hypoglycemia, but may cause side effects such as nausea, vomiting, and diarrhea. Metformin is often used as a first-line drug for the treatment of type II diabetes mellitus.

An Oral Hypoglycaemic Drug may be an effective medication for controlling blood glucose levels in patients with non-insulin-dependent diabetes mellitus type II. However, like any medicine, it should be taken only as prescribed by a doctor and under his supervision. If side effects occur or symptoms change, seek immediate medical attention.

Drug Oral Hypoglycemic, also known as oral hypoglycemic drugs, are medications that help reduce blood glucose. They are widely used to treat non-insulin-dependent diabetes mellitus, also known as type II diabetes mellitus.

Type II diabetes is characterized by impaired processing of glucose in the body and an increase in blood sugar levels. Unlike non-insulin-dependent diabetes mellitus (type I), in which the pancreas does not produce enough insulin, type II diabetes mellitus is caused by problems with the body's use of insulin.

Oral hypoglycemic agents help control blood glucose levels by improving tissue uptake of glucose and reducing glucose production in the liver. They are a convenient alternative to insulin because they are taken orally as tablets or capsules rather than requiring injections.

Among the main oral hypoglycemic drugs, the most common are drugs containing sulfonylureas and metformin.

Sulfonylureas, such as chlorpropamide, glibenclamide, and tolbutamide, work by stimulating the pancreas to produce more insulin. These drugs also help increase tissue sensitivity to insulin. They reduce blood glucose levels and help control type II diabetes.

Metformin, which belongs to the biguanide class, works differently. It reduces glucose production in the liver and improves glucose uptake into muscle and fat tissue. Metformin may also increase tissue sensitivity to insulin. This drug is widely used in the treatment of type II diabetes mellitus and may be prescribed as monotherapy or in combination with other oral hypoglycemic agents or insulin.

When prescribing oral hypoglycemic drugs, it is important to take into account the individual characteristics of the patient, such as age, health status, the presence of other diseases and the use of other medications. Regular monitoring of blood glucose levels and monitoring the effectiveness of treatment is also necessary.

Oral hypoglycemic medications are usually well tolerated but may cause some side effects such as hypoglycemia (low blood glucose levels), stomach upset, allergic reactions, and others. Therefore, it is important to follow your doctor's recommendations and regularly monitor your blood glucose levels.

Oral hypoglycemic agents are an important component of the treatment of type II diabetes mellitus. They help patients maintain normal blood glucose levels and prevent complications associated with uncontrolled diabetes. However, it should be remembered that drug treatment should always be combined with proper nutrition, physical activity and weight control.

In conclusion, oral hypoglycemic agents are an effective means of controlling blood glucose levels in patients with non-insulin-dependent diabetes mellitus (type II). Due to their convenient form of administration and the ability to increase tissue sensitivity to insulin, they help patients more easily manage their disease. However, before starting treatment, you should always consult with your doctor to choose the most appropriate drug and develop an individual treatment plan.

“Substances used to prepare a patient for anesthesia” was compiled by Professor V. A. Meer from the Department of Hospital Surgery, Faculty of Medicine, Moscow State University named after M. V. Lomonosov. Translation from German edited by Professor A.I. Gailis. Moscow military publishing house 1937 *** *** How are you? What is the algorithm of action? Do you need help?